Keyword: GSK

News

GSK Sees £70 million Short-term Brexit Cost

23.03.2018 - Britain’s largest pharmaceutical producer GlaxoSmithKline (GSK) has estimated that its costs related to Brexit, the country’s leaving the EU, could run as high as £70 million over...

News

GSK Fined $54 Million in Pay-for-Delay

12.03.2018 - GlaxoSmithKline has been fined $55 milllion (£37.6 million) in its appeal of a pay-for-delay case dating back to the early 2000s and involving its now off-patent antidepressant...

News

Interest in Consumer Drug Buys Waning?

06.02.2018 - Pharmaceutical companies’ interest in buying consumer health businesses is waning, with more players interested in shedding the activities than acquiring them, reports suggest...

News

GSK said Eyeing Bid for Vectura

18.01.2018 - GlaxoSmithKline (GSK), the UK’s largest drugmaker in terms of sales, is rumored to be preparing a bid for compatriot Vectura, an inhaled airways disease-focused player. The two...

News

Management Reshuffle at GlaxoSmithKline

12.01.2018 - A management reshuffle at the UK’s largest drugmaker, GlaxoSmithKline has caught the market’s attention, especially as it was carried through by closely watched CEO Emma Walmsley...

News

GSK Expands Stake in Saudi Subsidiary

03.01.2018 - UK drugmaker GlaxoSmithKline (GSK) has expanded its stake in its Saudi subsidiary Glaxo Saudi Arabia Limited (GSAL) by 26% to 75%. With an investment of more than $243 million, the...

News

UK Life Science Boom despite Brexit?

05.12.2017 - As a UK Parliament-select committee prepared for a public evidence session on Dec. 5, examining scenarios for trading arrangements with the UK post-Brexit, reports were circulating...

News

FDA Approves new Two-drug HIV Treatment

29.11.2017 - The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune...